← Eichor
Study identifier: NCT06805942 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis

Condition: Plantar Fasciitis of Both Feet  ·  Sponsor: IR Centers

PhaseNA
Planned participants10
Who can joinAll sexes, 22 Years to 100 Years
Healthy volunteersNo

About this study

This study evaluates the feasibility and safety of using Lipiodol (ethiodized oil) as an investigational embolic agent for treating pain caused by plantar fasciitis. Participants will undergo a minimally invasive procedure called plantar fascia embolization (PFE) to reduce inflammation and pain in the affected area. The study aims to assess changes in pain levels, foot function, and any potential side effects over a six-month follow-up period.

This description comes directly from the study's public registry record.

Talk to the study team

Sindhuja Kommidi Clinical Research Coordinator, MS  ·  7327831259  ·  sindhu@ircenters.com

Always discuss trial participation with your own doctor first.

Locations (1)

IR CentersFalls Church, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06805942